Global In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015

Summary

This report is an essential source for key information and data relating to global in vitro diagnostics market. The report provides global and country level, detailed and comprehensive coverage of market and category revenue, distribution and company share information. It also provides company profiles, pipeline products, news and financial deals in the global in vitro diagnostics market.

Scope

- This report provides detailed data on country-wise market size in countries such as United States, Germany, United Kingdom, France, Italy, Spain, Japan, Canada, China, India, Australia, Brazil.
- It provides data on market size by value for in the categories in in vitro diagnostics devices market such as In Vitro Diagnostics, Clinical Chemistry Test Reagents, Immunochemistry Test Reagents, Blood Test Reagents, Microbiology Test Reagents, Infectious Immunology, Test Reagents, Genetic Test Reagents, Self Testing, and Instruments.
- It gives key company share information for leading competitors, revenues by distribution channel and forecasts of market values at global and country level.
- It also provides overview of the market structure, key trends, drivers and restraints, future outlook, competitive landscape and key developments.
- All figures are based on rigorous research methodologies including in-depth primary and secondary research.

Reasons to buy

- A single source to fulfill all of your business and competitor intelligence needs
- Gain a strong understanding of the in vitro diagnostics devices market at a global level, with break downs for 12 countries
- Evaluate and compare the attractiveness of the market in different geographies.
- Identify growth segments and opportunities in the industry.
- Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched.
- Analyze the competitiveness of the market in different countries and regions and identify hotspots.
- Develop strategies based on the latest product, brand, expansion and research and development news.
- Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market.
- Identify and analyze the strengths and weaknesses of the industry incumbent
 

F. Hoffmann-La Roche Ltd.
Siemens Healthcare
Sysmex Corporation
Abbott Laboratories
Beckman Coulter, Inc.
Ortho-Clinical Diagnostics Inc.
OLYMPUS CORPORATION
Qiagen N.V.
bioMerieux S.A.
Bio-Rad Laboratories, Inc.
Phadia AB
DiaSorin S.p.A
Becton, Dickinson and Company
Gen-Probe Incorporated
Inverness Medical Innovations, Inc.
Ventana Medical Systems, Inc.
Hologic, Inc.
Dade Behring Holdings, Inc.
Calypte Biomedical Corporation
CytoCore, Inc.
Daxor Corporation
IRIS International, Inc.
Onconome, Inc.
Streck, Inc.
Targeted Diagnostics & Therapeutics, Inc.
Biovest International, Inc.
Biomeda Corp.
Quidel Corporation
American Bio Medica Corporation
AMPCOR Technologies, Inc.
Laboratory Corporation of America Holdings
American Diagnostica Inc.
GRANT Life Sciences, Inc.
Luminex Corporation
Akonni Biosystems Inc
Progentech USA, Inc.
Source MDx
GeneWorks Pty. Ltd.
Astral Scientific Pty Ltd
Eiken Chemical Co.,Ltd.
Cosmo Bio Co., Ltd.
Techno Medica Co., Ltd.
China Medical Technologies, Inc.
Beijing Pason Pharmaceuticals Inc.
Jingmei Biotech Co.,Ltd.
Beijing Bio-Ekon Biotechnology Co., Ltd.
China Sky One Medical, Inc
 

1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
3 Definitions of the Markets Covered in the Report
3.1 In Vitro Diagnostics
3.2 Clinical Chemistry
3.3 Genetic Testing
3.4 Haematology
3.5 Histology And Cytology
3.6 Immuno Chemistry
3.7 Infectious Immunology
3.8 Microbiology Culture
4 Global In Vitro Diagnostics
4.1 In Vitro Diagnostics, Global, Overall Revenue ($ mn), 2000-2015
4.2 In Vitro Diagnostics, Global, Company Share (2007-2008)
5 In Vitro Diagnostics In United States
5.1 In Vitro Diagnostics, United States, Overall Revenue ($ mn), 2000-2015
5.2 In Vitro Diagnostics, United States, Distribution Share (2007-2008)
5.3 In Vitro Diagnostics, United States, Company Share (2007-2008)
6 In Vitro Diagnostics In Japan
6.1 In Vitro Diagnostics, Japan, Overall Revenue ($ mn), 2000-2015
6.2 In Vitro Diagnostics, Japan, Distribution Share (2007-2008)
6.3 In Vitro Diagnostics, Japan, Company Share (2007-2008)
7 In Vitro Diagnostics In Germany
7.1 In Vitro Diagnostics, Germany, Overall Revenue ($ mn), 2000-2015
7.2 In Vitro Diagnostics, Germany, Distribution Share (2007-2008)
7.3 In Vitro Diagnostics, Germany, Company Share (2007-2008)
8 In Vitro Diagnostics In Italy
8.1 In Vitro Diagnostics, Italy, Overall Revenue ($ mn), 2000-2015
8.2 In Vitro Diagnostics, Italy, Distribution Share (2007-2008)
8.3 In Vitro Diagnostics, Italy, Company Share (2007-2008)
9 In Vitro Diagnostics In France
9.1 In Vitro Diagnostics, France, Overall Revenue ($ mn), 2000-2015
9.2 In Vitro Diagnostics, France, Distribution Share (2007-2008)
9.3 In Vitro Diagnostics, France, Company Share (2007-2008)
10 In Vitro Diagnostics In China
10.1 In Vitro Diagnostics, China, Overall Revenue ($ mn), 2000-2015
10.2 In Vitro Diagnostics, China, Distribution Share (2007-2008)
10.3 In Vitro Diagnostics, China, Company Share (2007-2008)
11 In Vitro Diagnostics In Spain
11.1 In Vitro Diagnostics, Spain, Overall Revenue ($ mn), 2000-2015
11.2 In Vitro Diagnostics, Spain, Distribution Share (2007-2008)
11.3 In Vitro Diagnostics, Spain, Company Share (2007-2008)
12 In Vitro Diagnostics In United Kingdom
12.1 In Vitro Diagnostics, United Kingdom, Overall Revenue ($ mn), 2000-2015
12.2 In Vitro Diagnostics, United Kingdom, Distribution Share (2007-2008)
12.3 In Vitro Diagnostics, United Kingdom, Company Share (2007-2008)
13 In Vitro Diagnostics In Brazil
13.1 In Vitro Diagnostics, Brazil, Overall Revenue ($ mn), 2000-2015
13.2 In Vitro Diagnostics, Brazil, Distribution Share (2007-2008)
13.3 In Vitro Diagnostics, Brazil, Company Share (2007-2008)
14 In Vitro Diagnostics In Canada
14.1 In Vitro Diagnostics, Canada, Overall Revenue ($ mn), 2000-2015
14.2 In Vitro Diagnostics, Canada, Distribution Share (2007-2008)
14.3 In Vitro Diagnostics, Canada, Company Share (2007-2008)
15 In Vitro Diagnostics In India
15.1 In Vitro Diagnostics, India, Overall Revenue ($ mn), 2000-2015
15.2 In Vitro Diagnostics, India, Distribution Share (2007-2008)
15.3 In Vitro Diagnostics, India, Company Share (2007-2008)
16 In Vitro Diagnostics In Australia
16.1 In Vitro Diagnostics, Australia, Overall Revenue ($ mn), 2000-2015
16.2 In Vitro Diagnostics, Australia, Distribution Share (2007-2008)
16.3 In Vitro Diagnostics, Australia, Company Share (2007-2008)
17 Overview of Key Companies in Global In Vitro Diagnostics Market
17.1 F. Hoffmann-La Roche Ltd.
17.2 Siemens Healthcare
17.3 Sysmex Corporation
17.4 Abbott Laboratories
17.5 Beckman Coulter, Inc.
17.6 Ortho-Clinical Diagnostics Inc.
17.7 OLYMPUS CORPORATION
17.8 Qiagen N.V.
17.9 bioMerieux S.A.
17.10 Bio-Rad Laboratories, Inc.
17.11 Phadia AB
17.12 DiaSorin S.p.A
17.13 Becton, Dickinson and Company
17.14 Gen-Probe Incorporated
17.15 Inverness Medical Innovations, Inc.
17.16 Ventana Medical Systems, Inc.
17.17 Hologic, Inc.
17.18 Dade Behring Holdings, Inc.
17.19 Calypte Biomedical Corporation
17.20 CytoCore, Inc.
17.21 Daxor Corporation
17.22 IRIS International, Inc.
17.23 Onconome, Inc.
17.24 Streck, Inc.
17.25 Targeted Diagnostics & Therapeutics, Inc.
17.26 Biovest International, Inc.
17.27 Biomeda Corp.
17.28 Quidel Corporation
17.29 American Bio Medica Corporation
17.30 AMPCOR Technologies, Inc.
17.31 Laboratory Corporation of America Holdings
17.32 American Diagnostica Inc.
17.33 GRANT Life Sciences, Inc.
17.34 Luminex Corporation
17.35 Akonni Biosystems Inc
17.36 Progentech USA, Inc.
17.37 Source MDx
17.38 GeneWorks Pty. Ltd.
17.39 Astral Scientific Pty Ltd
17.40 Eiken Chemical Co.,Ltd.
17.41 Cosmo Bio Co., Ltd.
17.42 Techno Medica Co., Ltd.
17.43 China Medical Technologies, Inc.
17.44 Beijing Pason Pharmaceuticals Inc.
17.45 Jingmei Biotech Co.,Ltd.
17.46 Beijing Bio-Ekon Biotechnology Co., Ltd.
17.47 China Sky One Medical, Inc.
18 Financial Deals Landscape
18.1 Merger
18.2 Acquisition
18.3 Partnerships
19 Recent Developments
19.1 Strategy And Business Planning
19.2 Legal and Regulatory
19.3 Government and Public Interest
19.4 Other Significant Developments
20 Appendix
20.1 Global Markets Direct Research Methodology
20.2 Secondary Research
20.3 Primary Research
20.4 Models
20.5 Forecasts
20.6 Expert Panel Validation
20.7 Currency Conversion
20.8 Contact Us
20.9 Disclaimer
 

1.1 List of Tables
Table 1: In Vitro Diagnostics, Global, Overall Revenue ($ mn), 2000-2015 37
Table 2: Global In Vitro Diagnostics Market, Cross- Category Analysis, 2000-2015 38
Table 3: In Vitro Diagnostics, Global, Overall Revenue ($ mn), Historic, 2000-2008 40
Table 4: In Vitro Diagnostics, Global, Overall Revenue ($ mn), Forecast, 2008-2015 42
Table 5: In Vitro Diagnostics, Global, Company Share by Revenue ($ mn), 2007-2008 43
Table 6: In Vitro Diagnostics, United States, Overall Revenue ($ mn), 2000-2015 44
Table 7: In Vitro Diagnostics, United States, Overall Revenue ($ mn), Historic, 2000-2008 46
Table 8: In Vitro Diagnostics, United States, Overall Revenue ($ mn), Forecast, 2008-2015 48
Table 9: Clinical Chemistry, United States, Distribution Share by Revenue ($mn), 2007-2008 49
Table 10: Genetic Testing, United States, Distribution Share by Revenue ($mn), 2007-2008 49
Table 11: Haematology, United States, Distribution Share by Revenue ($mn), 2007-2008 50
Table 12: Histology And Cytology, United States, Distribution Share by Revenue ($mn), 2007-2008 50
Table 13: Immuno Chemistry, United States, Distribution Share by Revenue ($mn), 2007-2008 51
Table 14: Infectious Immunology, United States, Distribution Share by Revenue ($mn), 2007-2008 51
Table 15: Microbiology Culture, United States, Distribution Share by Revenue ($mn), 2007-2008 52
Table 16: In Vitro Diagnostics, United States, Company Share by Revenue ($ mn), 2007-2008 53
Table 17: Clinical Chemistry, United States, Company Share by Revenue ($ mn), 2007-2008 54
Table 18: Genetic Testing, United States, Company Share by Revenue ($ mn), 2007-2008 55
Table 19: Haematology, United States, Company Share by Revenue ($ mn), 2007-2008 56
Table 20: Histology And Cytology, United States, Company Share by Revenue ($ mn), 2007-2008 57
Table 21: Immuno Chemistry, United States, Company Share by Revenue ($ mn), 2007-2008 59
Table 22: Infectious Immunology, United States, Company Share by Revenue ($ mn), 2007-2008 61
Table 23: Microbiology Culture, United States, Company Share by Revenue ($ mn), 2007-2008 62
Table 24: In Vitro Diagnostics, Japan, Overall Revenue ($ mn), 2000-2015 63
Table 25: In Vitro Diagnostics, Japan, Overall Revenue ($ mn), Historic, 2000-2008 65
T